SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements
SEC Accession No. 0001193125-11-084419
Filing Date
2011-03-31
Accepted
2011-03-31 13:06:48
Documents
18
Period of Report
2011-05-18
Filing Date Changed
2011-03-31
Effectiveness Date
2011-03-31

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE NOTICE AND PROXY STATEMENT ddef14a.htm DEF 14A 555645
2 GRAPHIC g148950g08h65.jpg GRAPHIC 2378
3 GRAPHIC g148950g16c56.jpg GRAPHIC 7877
4 GRAPHIC g148950g19t06.jpg GRAPHIC 3216
5 GRAPHIC g148950g19u18.jpg GRAPHIC 2727
6 GRAPHIC g148950g26n66.jpg GRAPHIC 2588
7 GRAPHIC g148950g34i31.jpg GRAPHIC 2477
8 GRAPHIC g148950g42t69.jpg GRAPHIC 2271
9 GRAPHIC g148950g44o11.jpg GRAPHIC 2664
10 GRAPHIC g148950g46b90.jpg GRAPHIC 3446
11 GRAPHIC g148950g49v58.jpg GRAPHIC 2656
12 GRAPHIC g148950g51j04.jpg GRAPHIC 2643
13 GRAPHIC g148950g57q80.jpg GRAPHIC 3016
14 GRAPHIC g148950g64n06.jpg GRAPHIC 2558
15 GRAPHIC g148950g69v43.jpg GRAPHIC 2454
16 GRAPHIC g148950g74t23.jpg GRAPHIC 2345
17 GRAPHIC g148950g83z96.jpg GRAPHIC 2370
18 GRAPHIC g148950g97n83.jpg GRAPHIC 2656
  Complete submission text file 0001193125-11-084419.txt   629018
Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-27570 | Film No.: 11724938
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director 1